已收录 268921 条政策
 政策提纲
  • 暂无提纲
Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report
[摘要] Inflammatory breast cancer (IBC) is the most aggressive form of primary breast cancer.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 泌尿医学
[关键词] Multidisciplinary treatment;Inflammatory breast cancer;Combination neoadjuvant chemotherapy [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文